Back
Enterprise Products Partners LP Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Sell
49
EPD
Enterprise Products Partners LP
Last Price:
$31.70
Seasonality Move:
3.73%
Sell
46
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$23.45
Seasonality Move:
6.84%
Sell
49
Enterprise Products Partners LP (EPD)
is a Sell
Is Enterprise Products Partners LP a Buy, Sell or Hold?
-
The current Enterprise Products Partners LP [EPD] share price is $31.73. The Score for EPD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
EPD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.35. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPD Stock Price Chart
What is Enterprise Products Partners LP's stock price today?
-
The Enterprise Products Partners LP share price today is $31.73Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPD is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EPD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 43.06 | Sell |
| Chaikin Money Flow: | -3658187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.9 - 32.4) | Sell |
| Bollinger Bands (100): | (31.09 - 32.21) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 57.28 | Buy |
| Chaikin Money Flow: | 2714421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.91 - 22.31) | Buy |
| Bollinger Bands (100): | (18.08 - 22.48) | Buy |
EPD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.01 | Sell |
| 20-day SMA: | 32.09 | Sell |
| 50-day SMA: | 31.85 | Sell |
| 200-day SMA: | 31.54 | Buy |
| 8-day EMA: | 32.01 | Sell |
| 20-day EMA: | 32.05 | Sell |
| 50-day EMA: | 31.9 | Sell |
| 200-day EMA: | 31.56 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.75 | Buy |
| 20-day SMA: | 21.66 | Buy |
| 50-day SMA: | 20.64 | Buy |
| 200-day SMA: | 28.51 | Sell |
| 8-day EMA: | 21.66 | Buy |
| 20-day EMA: | 21.44 | Buy |
| 50-day EMA: | 21.01 | Buy |
| 200-day EMA: | 36.4 | Sell |
Enterprise Products Partners LP Earnings Growth & EPD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.16 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.78 per share, and an increase next year of $0.24 per share.
Enterprise Products Partners LP Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||